Johnny John compensation by year
DELCATH SYSTEMS Summary Compensation Table · all 2 fiscal years held| Component | FY2020 | FY2021 |
|---|---|---|
| Salary | $256,632 | $325,557 |
| Bonus | $23,740 | $58,078 |
| Stock awards | $0 | $0 |
| Option awards | $849,395 | $492,142 |
| Non-equity incentive | $0 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $0 | $0 |
| Total | $1,129,767 | $875,777 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: DELCATH SYSTEMS, INC. DEF 14A filed April 4, 2022, accession 0001193125-22-095123, and prior-year filings. Open the filing on EDGAR.
How this page was built: the DELCATH SYSTEMS, INC. filed document, accession 0001193125-22-095123. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2022.
Equity holdings
unvested awards at FY2021 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| Option | 43,740 | — | $11.67 |
| Option | 38,889 | — | $10.16 |
Per the Outstanding Equity Awards at Fiscal Year-End table in DELCATH SYSTEMS, INC.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.
Insider transactions since the last proxy
2 Form 4 lines since the FY2021 proxy (filed April 4, 2022)current to 2026-11-21 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2023-06-12 | Grant or award derivative | — | 59,813 | $0.00 | 59,813 |
| 2023-02-08 | Grant or award derivative | — | 46,800 | $0.00 | 46,800 |
The 2 most recent of 2 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
DELCATH SYSTEMS’s named executive officers, FY2021
as the company reported each| Named executive officer | Role | FY2021 total |
|---|---|---|
| Gerard Michel | Chief Executive Officer | $1,914,402 |
| John Purpura | Chief Operating Officer | $925,489 |
| Johnny John · this page | Senior Vice President Clinical Development and Medical Affairs | $875,777 |
The full DELCATH SYSTEMS compensation record
free company briefThis page is one person within DELCATH SYSTEMS's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are DELCATH SYSTEMS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.